Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Glioma and MDM2[original query] |
---|
Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Jul 14 (7): 1774-83. Wiencke John K, Aldape Kenneth, McMillan Alex, Wiemels Joe, Moghadassi Michelle, Miike Rei, Kelsey Karl T, Patoka Joe, Long Jeff, Wrensch Margar |
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Aug 16 (8): 1655-61. Rajaraman Preetha, Wang Sophia S, Rothman Nathaniel, Brown Merideth M, Black Peter M, Fine Howard A, Loeffler Jay S, Selker Robert G, Shapiro William R, Chanock Stephen J, Inskip Peter |
Single nucleotide polymorphism 309 affects murin-double-minute 2 protein expression but not glioma tumorigenesis. Neurologia medico-chirurgica 2007 May 47 (5): 203-8; discussion 208-9. Tsuiki Hiromasa, Nishi Toru, Takeshima Hideo, Yano Shigetoshi, Nakamura Hideo, Makino Keishi, Kuratsu Jun-Ic |
Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma. Genetics and molecular research : GMR 2012 11 (4): 3618-28. Zhang J N, Yi S H, Zhang X H, Liu X Y, Mao Q, Li S Q, Xiong W H, Qiu Y M, Chen T, Ge J |
Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors. Anticancer research 2015 Jul 35 (7): 3933-42. Kafadar Ali, Küçükhüseyin Özlem, Turan Saime, Yenilmez Ezgi Nurdan, Tunoglu Servet, Zeybek Umit, Kaynar Mehmet Yasar, Kemerdere Rahsan, Yaylim Ilh |
Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2017 30 (5): 361-371. Houdova Megova M, Drábek J, Dwight Z, Trojanec R, Koudeláková V, Vrbková J, Kalita O, Mlcochova S, Rabcanova M, Hajdúch |
Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16. Life sciences 2019 4 225 55-63. Wei Yuzhen, Wang Fang, Sang Ben, Xu Zhen, Yang Dong |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: